(Q45882846)

17 December 2017

title

Gene therapy with recombinant adenovirus vectors: evaluation of the host immune response (English)

1 reference

17 December 2017

0 references

1 reference

Christ M

1 reference

17 December 2017

Lusky M

1 reference

17 December 2017

Stoeckel F

1 reference

17 December 2017

Dreyer D

1 reference

17 December 2017

Dieterlé A

1 reference

17 December 2017

Michou AI

1 reference

17 December 2017

Pavirani A

1 reference

17 December 2017

Mehtali M

1 reference

17 December 2017

publication date

1 June 1997

1 reference

17 December 2017

published in

immunology Letters

1 reference

17 December 2017

volume

1 reference

17 December 2017

issue

1-3

1 reference

17 December 2017

page(s)

19-25

1 reference

17 December 2017

Trans-complementation of E1-deleted adenovirus: a new vector to reduce the possibility of codissemination of wild-type and recombinant adenoviruses

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Characteristics of a human cell line transformed by DNA from human adenovirus type 5

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Adenovirus as an expression vector in muscle cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

[Genetic therapy for hemophiliacs--therapeutic potential and technological limits]

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Adenovirus-mediated transfer of human factor IX gene in immunodeficient and normal mice: evidence for prolonged stability and activity of the transgene in liver

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Use of transient CD4 lymphocyte depletion to prolong transgene expression of E1-deleted adenoviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Anti-T cell receptor monoclonal antibody prolongs transgene expression following adenovirus-mediated in vivo gene transfer to mouse synovium.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2897%2900049-7

7 January 2021

10.1016/S0165-2478(97)00049-7

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017